Jerry Zifodya is a Respiratory physician affiliated with Tulane University. OpenAlex indexes 52 publications with 967 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1415 Tulane Ave
New Orleans, LA 70112
Telephone
504-988-5263Registry record last updated 30 Oct 2019.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20231 payment
- Siemens Medical Solutions USA, Inc.Program year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Anticholinergic100%Incruse Ellipta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Clinical and biologic risk factors for post-tuberculosis lung disease (PTLD) in people with and without HIV
Tulane University of Louisiana
FY2026$165,348K23HL164289 - Clinical and biologic risk factors for post-tuberculosis lung disease (PTLD) in people with and without HIV
Tulane University of Louisiana
FY2026$13,284K23HL164289 - Clinical and biologic risk factors for post-tuberculosis lung disease (PTLD) in people with and without HIV
Tulane University of Louisiana
FY2025$152,064K23HL164289
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents
Cochrane Database of Systematic Reviews
2025 - Pulmonary Tuberculosis Infectiousness of Persons Identified Through Active and Passive Case-finding in a High-burden Setting
Open Forum Infectious Diseases
2025 - A systematic review of the immuno-inflammatory dysfunction secondary to viral hemorrhagic fevers; Ebola and Lassa fever
PLoS neglected tropical diseases
2025 - Persistently high TB prevalence in Nairobi County neighbourhoods, 2015–2022
PLOS Global Public Health
2025 - Leveraging HIV Research Infrastructure for Lung Disease Screening by Spirometry in Tanzania
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Erik Castle, MD
Tulane University
John Schieffelin, MD
Tulane University
Thierry Lejemtel, MD
Tulane University
Robert Hendel, MD
Tulane University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”